Artivion, Inc. revenue by segment AORT

Annual Quarterly

Artivion, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was North America at $221.7 million, 50% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Aortic Stent Grafts at $159.4 million, 36% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Revenue	482	441	389	354	314	299	253	276	263	190	180
Operating segments
North America	—	222 +12.0% share 50.2%	198 +5.5% share 50.9%	188 +12.0% share 53.0%	168 +6.1% share 53.4%	158 share 52.8%	—	—	—	—	—
Europe The Middle East And Africa Segments	—	151 +15.1% share 34.3%	132 +14.5% share 33.8%	115 +10.3% share 32.4%	104 -4.5% share 33.2%	109 share 36.5%	—	—	—	—	—
Asia Pacific	—	44 +18.9% share 10.0%	37 +10.8% share 9.6%	34 +20.0% share 9.5%	28 +28.9% share 8.9%	22 share 7.3%	—	—	—	—	—
Latin America	—	24 +9.6% share 5.4%	22 +21.5% share 5.6%	18 +27.2% share 5.1%	14 +39.1% share 4.5%	10 share 3.4%	—	—	—	—	—
Sales mix
Aortic Stent Grafts	—	159 +29.5% share 36.1%	123 +14.5% share 31.7%	107 +15.9% share 30.4%	93 share 29.6%	—	—	—	—	—	—
On X	—	102 share 23.1%	—	75 +16.6% share 21.1%	64 +11.4% share 20.4%	57 +19.4% share 19.2%	48 share 19.0%	—	—	—	—
Preservation Services	—	96 -2.9% share 21.6%	98 +5.9% share 25.3%	93 +11.2% share 26.2%	83 +8.0% share 26.6%	77 +4.5% share 25.8%	74 share 29.2%	—	—	—	—
Surgical Sealants	—	77 +3.7% share 17.4%	74 +8.6% share 19.0%	68 +4.0% share 19.2%	65 -7.5% share 20.8%	71 +13.9% share 23.7%	62 share 24.5%	—	—	—	—
Other Products	—	8 -12.5% share 1.8%	9 -17.0% share 2.4%	11 +34.3% share 3.2%	8 +2.3% share 2.7%	8 +8.2% share 2.7%	8 share 3.0%	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: AORT (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Kennesaw, GA
SEC filer status: Large accelerated filer
SEC CIK: 784199
Former names: CRYOLIFE INC (until Jan 6, 2022)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.